FIELD: medicine.
SUBSTANCE: biopsy material is examined within immunohistochemical analysis. At that localisation of E-cadgerine expression is determined. If membrane or membrane-reduced types of E-cadgerine expression prevail in tumour cells cryodestruction is recommended as therapy method. If cytoplasmic type of E-cadgerine expression prevails or E-cadgerine expression is absent, interstitial interferon-therapy followed with cryodestruction is recommended as therapy method.
EFFECT: method implies individual approach to selection of therapy in consideration of invasive power of tumour cells, and increases therapy efficiency.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIFFERENTIAL DIAGNOSIS OF RED LICHEN PLANUS AND LYCEOPLACY OF THE ORAL MUCOSA | 2017 |
|
RU2651050C1 |
| METHOD OF DIAGNOSTICS OF AUTOIMMUNE VIOLENT DERMATOSES | 2008 |
|
RU2352947C1 |
| DIFFERENTIAL DIAGNOSIS METHOD FOR DETERMINING SQUAMOUS CELL SKIN CARCINOMA AND KERATOACANTHOMA CASES | 2004 |
|
RU2279089C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF ACTINIC KERATOSIS AND SQUAMOUS CELL CARCINOMA OF SKIN | 2019 |
|
RU2703464C1 |
| METHOD OF ASSESSING THE AGGRESSIVE POTENTIAL OF BREAST CANCER OF THE NONSPECIFIC TYPE IDC/NOS TYPE CARCINOMA USING THE ANALYSIS OF TUMOR BUDDING | 2022 |
|
RU2796769C1 |
| METHOD FOR MODELING BASALIOMAS IN EXPERIMENTAL ANIMALS (RATS) | 2004 |
|
RU2270482C2 |
| METHOD OF SELECTING TACTICS OF TREATING ACTINIC KERATOSIS | 2012 |
|
RU2495628C1 |
| METHOD FOR SCREENING DIFFERENTIAL DIAGNOSIS OF PRECANCEROUS DISEASES AND CANCER OF THE ORAL MUCOSA (OM) | 2021 |
|
RU2754295C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTIC OF HIGH-GRADE DIFFERENTIATED ADENOCARCINOMAS AND ADENOMAS OF COLON | 2015 |
|
RU2599101C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF PULMONARY ADENOCARCINOMA | 2018 |
|
RU2706116C1 |
